相关实验视频
Updated: Mar 14, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.8K
与罗斯瓦斯塔丁使用相关的可逆血小板缺血症:一个病例报告
1Medicine, Al-Nafees Medical College, Isra University, Islamabad, PAK.
Cureus
|March 13, 2026
概括
罗斯瓦斯塔丁是一种常见的降胆固醇药物,可能会导致血小板数的可逆性下降 (血小板缺血). 这份病例报告表明,罗斯瓦斯塔丁是药物诱导的血小板缺血的潜在原因,需要进一步调查.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 心脏病学 心脏病学
背景情况:
- 类药物抑制HMG-CoA减少酶,这对胆固醇合成至关重要.
- 类药物被广泛用于失脂症和心血管疾病的预防.
- 已知的副作用包括骨髓痛,透氨酸炎和肌酸激酶的升高.
研究的目的:
- 报告可能与罗斯瓦斯塔丁使用相关的血小板缺血病例.
- 调查罗斯瓦斯塔丁与药物诱导的血小板缺血之间的关联.
- 突出罗苏瓦斯塔丁作为可逆血小板缺血的可能原因.
主要方法:
- 一个57岁的女性患有偶发性血小板缺血的病例报告.
- 通过全面评估,排除血小板缺血的其他原因.
- 文献审查以确定他类药物和血小板衰竭之间的先前关联.
- 停止使用罗斯瓦斯塔丁和监测血小板数量.
主要成果:
- 一名57岁的南亚女性出现了偶然的血小板缺血症.
- 罗斯瓦斯塔丁被确定为最可能的致病因子.
- 在停止使用罗斯瓦斯塔丁后的3至6个月内血小板数正常化.
- 没有先前的文献专门将罗斯瓦斯塔丁与血小板缺血联系起来.
结论:
- 罗斯瓦斯塔丁可能会导致可逆药物诱导的血小板缺血.
- 这一案例增加了已知的他类药物的不良影响.
- 需要进一步的研究来证实机制和关联.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Coronary Artery Disease V: Interprofessional Care
359
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Therapeutic Drug Monitoring: Affecting Factors
313
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
313

